chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Patient reports, within normal vaccine reaction until day 5 on 1/3/2021.  the injection site got bigger, itchy and more painful to touch.  On 1/6, saw PCP where it grew in size to 9 cm 7 cm.  PCP told patient they were going to report reaction.  Today, 1/12 things are better, site with quarter size redness but still a 4 or 5 pain level but only when touching site.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste in my mouth; This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: EL1284; expiration date: not known), via an unspecified route of administration on right arm on 06Jan2021 07:15 at single dose for covid-19 immunization, administered at hospital. Medical history included pacemaker for bradycardia w/syncopal episodes; and allergy to poppy seeds and pineapple. The patient is not pregnant at the time of vaccination. Concomitant medications included rosuvastatin calcium (CRESTOR), colecalciferol (VIT D3), and an unspecified multivitamin (other medications received within two weeks of vaccination). No other vaccines received within four weeks prior to covid vaccine. The patient previously took morphine and experienced drug allergy. The patient was not diagnosed with covid-19 prior to vaccination and had not been tested with covid-19 since the vaccination. The patient experienced metallic taste in her mouth approximately one minute after receiving the vaccine on 06Jan2021 07:15; it lingered for about six hours (13:15). The event was reported non-serious. The patient did not receive treatment for this event. The outcome of the event was recovered on 06Jan2021 13:15.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Heart rate increased, Joint swelling, Pyrexia
Clinical narrative: tachycardia (140 bpm); Fever above 101; myalgia; joint pain right arm, joint pain and swelling to right wrist; joint pain and swelling to right wrist; swollen lymph node on right side of body; weakness; skin redness and burning sensation; skin redness and burning sensation; tremors; gum pain; fatigue; migraine; sweating; back pain; first dose of bnt162b2 on 18Dec2020 at 16:00, second dose on 04Jan2021 at 08:00 AM; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELU140), via an unspecified route of administration on 04Jan2021 at 08:00 AM on Right arm at single dose for COVID-19 immunization. The patient medical history included had known allergies with Penicillin, bees and wasp. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol, retinol (VITAMIN A); colecalciferol (VITAMIN D); calcium phosphate dibasic, phytomenadione (VITAMIN K); cyanocobalamin (VITAMIN B12); levothyroxine, liothyronine (NP THYROID). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), via an unspecified route of administration on 18Dec2020 at 16:00 on Right arm at single dose for COVID-19 immunization. The patient experienced fever above 101, tachycardia (140 bpm), myalgia, joint pain right arm, joint pain and swelling to right wrist, swollen lymph node on right side of body, weakness, skin redness and burning sensation, tremors, gum pain, migraine, fatigue, sweating and back pain, all on 04Jan2021 at 20:00, events were resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. It was unknown if any treatment was received for events. The outcome of the events was not recovered. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Body temperature, Erythema
Clinical narrative: tachycardia (140 bpm); Fever above 101; myalgia; joint pain right arm, joint pain and swelling to right wrist; joint pain and swelling to right wrist; swollen lymph node on right side of body; weakness; skin redness and burning sensation; skin redness and burning sensation; tremors; gum pain; fatigue; migraine; sweating; back pain; first dose of bnt162b2 on 18Dec2020 at 16:00, second dose on 04Jan2021 at 08:00 AM; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELU140), via an unspecified route of administration on 04Jan2021 at 08:00 AM on Right arm at single dose for COVID-19 immunization. The patient medical history included had known allergies with Penicillin, bees and wasp. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol, retinol (VITAMIN A); colecalciferol (VITAMIN D); calcium phosphate dibasic, phytomenadione (VITAMIN K); cyanocobalamin (VITAMIN B12); levothyroxine, liothyronine (NP THYROID). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), via an unspecified route of administration on 18Dec2020 at 16:00 on Right arm at single dose for COVID-19 immunization. The patient experienced fever above 101, tachycardia (140 bpm), myalgia, joint pain right arm, joint pain and swelling to right wrist, swollen lymph node on right side of body, weakness, skin redness and burning sensation, tremors, gum pain, migraine, fatigue, sweating and back pain, all on 04Jan2021 at 20:00, events were resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. It was unknown if any treatment was received for events. The outcome of the events was not recovered. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Gingival pain, Heart rate, Hyperhidrosis, Inappropriate schedule of product administration
Clinical narrative: tachycardia (140 bpm); Fever above 101; myalgia; joint pain right arm, joint pain and swelling to right wrist; joint pain and swelling to right wrist; swollen lymph node on right side of body; weakness; skin redness and burning sensation; skin redness and burning sensation; tremors; gum pain; fatigue; migraine; sweating; back pain; first dose of bnt162b2 on 18Dec2020 at 16:00, second dose on 04Jan2021 at 08:00 AM; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELU140), via an unspecified route of administration on 04Jan2021 at 08:00 AM on Right arm at single dose for COVID-19 immunization. The patient medical history included had known allergies with Penicillin, bees and wasp. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol, retinol (VITAMIN A); colecalciferol (VITAMIN D); calcium phosphate dibasic, phytomenadione (VITAMIN K); cyanocobalamin (VITAMIN B12); levothyroxine, liothyronine (NP THYROID). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), via an unspecified route of administration on 18Dec2020 at 16:00 on Right arm at single dose for COVID-19 immunization. The patient experienced fever above 101, tachycardia (140 bpm), myalgia, joint pain right arm, joint pain and swelling to right wrist, swollen lymph node on right side of body, weakness, skin redness and burning sensation, tremors, gum pain, migraine, fatigue, sweating and back pain, all on 04Jan2021 at 20:00, events were resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. It was unknown if any treatment was received for events. The outcome of the events was not recovered. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Joint swelling, Lymphadenopathy, Migraine, Myalgia, Pyrexia
Clinical narrative: tachycardia (140 bpm); Fever above 101; myalgia; joint pain right arm, joint pain and swelling to right wrist; joint pain and swelling to right wrist; swollen lymph node on right side of body; weakness; skin redness and burning sensation; skin redness and burning sensation; tremors; gum pain; fatigue; migraine; sweating; back pain; first dose of bnt162b2 on 18Dec2020 at 16:00, second dose on 04Jan2021 at 08:00 AM; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELU140), via an unspecified route of administration on 04Jan2021 at 08:00 AM on Right arm at single dose for COVID-19 immunization. The patient medical history included had known allergies with Penicillin, bees and wasp. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol, retinol (VITAMIN A); colecalciferol (VITAMIN D); calcium phosphate dibasic, phytomenadione (VITAMIN K); cyanocobalamin (VITAMIN B12); levothyroxine, liothyronine (NP THYROID). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), via an unspecified route of administration on 18Dec2020 at 16:00 on Right arm at single dose for COVID-19 immunization. The patient experienced fever above 101, tachycardia (140 bpm), myalgia, joint pain right arm, joint pain and swelling to right wrist, swollen lymph node on right side of body, weakness, skin redness and burning sensation, tremors, gum pain, migraine, fatigue, sweating and back pain, all on 04Jan2021 at 20:00, events were resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. It was unknown if any treatment was received for events. The outcome of the events was not recovered. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Skin burning sensation, Tachycardia, Tremor
Clinical narrative: tachycardia (140 bpm); Fever above 101; myalgia; joint pain right arm, joint pain and swelling to right wrist; joint pain and swelling to right wrist; swollen lymph node on right side of body; weakness; skin redness and burning sensation; skin redness and burning sensation; tremors; gum pain; fatigue; migraine; sweating; back pain; first dose of bnt162b2 on 18Dec2020 at 16:00, second dose on 04Jan2021 at 08:00 AM; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELU140), via an unspecified route of administration on 04Jan2021 at 08:00 AM on Right arm at single dose for COVID-19 immunization. The patient medical history included had known allergies with Penicillin, bees and wasp. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol, retinol (VITAMIN A); colecalciferol (VITAMIN D); calcium phosphate dibasic, phytomenadione (VITAMIN K); cyanocobalamin (VITAMIN B12); levothyroxine, liothyronine (NP THYROID). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), via an unspecified route of administration on 18Dec2020 at 16:00 on Right arm at single dose for COVID-19 immunization. The patient experienced fever above 101, tachycardia (140 bpm), myalgia, joint pain right arm, joint pain and swelling to right wrist, swollen lymph node on right side of body, weakness, skin redness and burning sensation, tremors, gum pain, migraine, fatigue, sweating and back pain, all on 04Jan2021 at 20:00, events were resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, patient had not been tested for COVID-19. It was unknown if any treatment was received for events. The outcome of the events was not recovered. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Arthralgia, Back pain, Chills, Fatigue
Clinical narrative: light sensitivity; joint pain in my fingers while typing/worsening joint; muscle soreness in my upper back/worsening muscle pain everywhere; a headache; a slightly sore throat/worsening sore throat; a fever; chills; nausea; severe fatigue; tingling; numbness in all extremities at random locations; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), intramuscularly on 05Jan2021 at 18:30 on Left arm at single dose for COVID-19 immunization in hospital. None other vaccine received on same date. The patient medical history included Hypothyroid Generally healthy; Hx of depression and ADHD (Attention deficit hyperactivity disorder); and prior to vaccination, patient was diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE); ibuprofen; cetirizine hydrochloride (ZYRTEC). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscularly on 15Dec2020 at 18:30 on Left arm at single dose for COVID-19 immunization; and had known allergies with Sulfa and ciprofloxacin hydrochloride monohydrate (CIPRO) drugs, tramadol and oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET). The patient experienced on 06Jan2021 at approximately 9am hour, she noticed joint pain in her fingers while typing, muscle soreness in her upper back, a headache, and a slightly sore throat. It quickly went down hill with a fever, chills, worsening joint and muscle pain everywhere, nausea, severe fatigue, worsening sore throat, tingling and numbness in all extremities at random locations. Then at 3pm, about 21 hours since vaccination-fever had broken once but returned quickly, and severe headache with light sensitivity. The joint pain and numbness had faded but she was left with severe muscle soreness, like she was in a car accident. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the event. The outcome of the event Muscle soreness was not recovered, outcome of the other events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Injection site pain, Myalgia, Nausea
Clinical narrative: light sensitivity; joint pain in my fingers while typing/worsening joint; muscle soreness in my upper back/worsening muscle pain everywhere; a headache; a slightly sore throat/worsening sore throat; a fever; chills; nausea; severe fatigue; tingling; numbness in all extremities at random locations; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), intramuscularly on 05Jan2021 at 18:30 on Left arm at single dose for COVID-19 immunization in hospital. None other vaccine received on same date. The patient medical history included Hypothyroid Generally healthy; Hx of depression and ADHD (Attention deficit hyperactivity disorder); and prior to vaccination, patient was diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE); ibuprofen; cetirizine hydrochloride (ZYRTEC). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscularly on 15Dec2020 at 18:30 on Left arm at single dose for COVID-19 immunization; and had known allergies with Sulfa and ciprofloxacin hydrochloride monohydrate (CIPRO) drugs, tramadol and oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET). The patient experienced on 06Jan2021 at approximately 9am hour, she noticed joint pain in her fingers while typing, muscle soreness in her upper back, a headache, and a slightly sore throat. It quickly went down hill with a fever, chills, worsening joint and muscle pain everywhere, nausea, severe fatigue, worsening sore throat, tingling and numbness in all extremities at random locations. Then at 3pm, about 21 hours since vaccination-fever had broken once but returned quickly, and severe headache with light sensitivity. The joint pain and numbness had faded but she was left with severe muscle soreness, like she was in a car accident. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the event. The outcome of the event Muscle soreness was not recovered, outcome of the other events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Pain in extremity, Paraesthesia, Photophobia, Pyrexia
Clinical narrative: light sensitivity; joint pain in my fingers while typing/worsening joint; muscle soreness in my upper back/worsening muscle pain everywhere; a headache; a slightly sore throat/worsening sore throat; a fever; chills; nausea; severe fatigue; tingling; numbness in all extremities at random locations; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), intramuscularly on 05Jan2021 at 18:30 on Left arm at single dose for COVID-19 immunization in hospital. None other vaccine received on same date. The patient medical history included Hypothyroid Generally healthy; Hx of depression and ADHD (Attention deficit hyperactivity disorder); and prior to vaccination, patient was diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE); ibuprofen; cetirizine hydrochloride (ZYRTEC). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscularly on 15Dec2020 at 18:30 on Left arm at single dose for COVID-19 immunization; and had known allergies with Sulfa and ciprofloxacin hydrochloride monohydrate (CIPRO) drugs, tramadol and oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET). The patient experienced on 06Jan2021 at approximately 9am hour, she noticed joint pain in her fingers while typing, muscle soreness in her upper back, a headache, and a slightly sore throat. It quickly went down hill with a fever, chills, worsening joint and muscle pain everywhere, nausea, severe fatigue, worsening sore throat, tingling and numbness in all extremities at random locations. Then at 3pm, about 21 hours since vaccination-fever had broken once but returned quickly, and severe headache with light sensitivity. The joint pain and numbness had faded but she was left with severe muscle soreness, like she was in a car accident. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the event. The outcome of the event Muscle soreness was not recovered, outcome of the other events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Hypoaesthesia
Clinical narrative: light sensitivity; joint pain in my fingers while typing/worsening joint; muscle soreness in my upper back/worsening muscle pain everywhere; a headache; a slightly sore throat/worsening sore throat; a fever; chills; nausea; severe fatigue; tingling; numbness in all extremities at random locations; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), intramuscularly on 05Jan2021 at 18:30 on Left arm at single dose for COVID-19 immunization in hospital. None other vaccine received on same date. The patient medical history included Hypothyroid Generally healthy; Hx of depression and ADHD (Attention deficit hyperactivity disorder); and prior to vaccination, patient was diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE); ibuprofen; cetirizine hydrochloride (ZYRTEC). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscularly on 15Dec2020 at 18:30 on Left arm at single dose for COVID-19 immunization; and had known allergies with Sulfa and ciprofloxacin hydrochloride monohydrate (CIPRO) drugs, tramadol and oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET). The patient experienced on 06Jan2021 at approximately 9am hour, she noticed joint pain in her fingers while typing, muscle soreness in her upper back, a headache, and a slightly sore throat. It quickly went down hill with a fever, chills, worsening joint and muscle pain everywhere, nausea, severe fatigue, worsening sore throat, tingling and numbness in all extremities at random locations. Then at 3pm, about 21 hours since vaccination-fever had broken once but returned quickly, and severe headache with light sensitivity. The joint pain and numbness had faded but she was left with severe muscle soreness, like she was in a car accident. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the event. The outcome of the event Muscle soreness was not recovered, outcome of the other events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Oropharyngeal pain, Paraesthesia, Photophobia
Clinical narrative: light sensitivity; joint pain in my fingers while typing/worsening joint; muscle soreness in my upper back/worsening muscle pain everywhere; a headache; a slightly sore throat/worsening sore throat; a fever; chills; nausea; severe fatigue; tingling; numbness in all extremities at random locations; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), intramuscularly on 05Jan2021 at 18:30 on Left arm at single dose for COVID-19 immunization in hospital. None other vaccine received on same date. The patient medical history included Hypothyroid Generally healthy; Hx of depression and ADHD (Attention deficit hyperactivity disorder); and prior to vaccination, patient was diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE); ibuprofen; cetirizine hydrochloride (ZYRTEC). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscularly on 15Dec2020 at 18:30 on Left arm at single dose for COVID-19 immunization; and had known allergies with Sulfa and ciprofloxacin hydrochloride monohydrate (CIPRO) drugs, tramadol and oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET). The patient experienced on 06Jan2021 at approximately 9am hour, she noticed joint pain in her fingers while typing, muscle soreness in her upper back, a headache, and a slightly sore throat. It quickly went down hill with a fever, chills, worsening joint and muscle pain everywhere, nausea, severe fatigue, worsening sore throat, tingling and numbness in all extremities at random locations. Then at 3pm, about 21 hours since vaccination-fever had broken once but returned quickly, and severe headache with light sensitivity. The joint pain and numbness had faded but she was left with severe muscle soreness, like she was in a car accident. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the event. The outcome of the event Muscle soreness was not recovered, outcome of the other events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: light sensitivity; joint pain in my fingers while typing/worsening joint; muscle soreness in my upper back/worsening muscle pain everywhere; a headache; a slightly sore throat/worsening sore throat; a fever; chills; nausea; severe fatigue; tingling; numbness in all extremities at random locations; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), intramuscularly on 05Jan2021 at 18:30 on Left arm at single dose for COVID-19 immunization in hospital. None other vaccine received on same date. The patient medical history included Hypothyroid Generally healthy; Hx of depression and ADHD (Attention deficit hyperactivity disorder); and prior to vaccination, patient was diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE); ibuprofen; cetirizine hydrochloride (ZYRTEC). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscularly on 15Dec2020 at 18:30 on Left arm at single dose for COVID-19 immunization; and had known allergies with Sulfa and ciprofloxacin hydrochloride monohydrate (CIPRO) drugs, tramadol and oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET). The patient experienced on 06Jan2021 at approximately 9am hour, she noticed joint pain in her fingers while typing, muscle soreness in her upper back, a headache, and a slightly sore throat. It quickly went down hill with a fever, chills, worsening joint and muscle pain everywhere, nausea, severe fatigue, worsening sore throat, tingling and numbness in all extremities at random locations. Then at 3pm, about 21 hours since vaccination-fever had broken once but returned quickly, and severe headache with light sensitivity. The joint pain and numbness had faded but she was left with severe muscle soreness, like she was in a car accident. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the event. The outcome of the event Muscle soreness was not recovered, outcome of the other events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Fatigue, Headache
Clinical narrative: Sore arm; fatigue; headache; sore eyea; This is a spontaneous report from a contactable other HCP. A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at 06Jan2021 06:45AM at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. The facility type vaccine was hospital. The patient medical history was not reported. Concomitant medication included hydrochlorothiazide, losartan potassium (HYZAAR), ibuprofen, omeprazole. The patient previously took amoxicillin and experienced drug hypersensitivity. Patient received the first dose of BNT162B2 at 16Dec2020 12:45 PM left arm for covid-19 immunization, then on 22Dec2020, patient tested Nasal Swab, the result was positive. Patient was not diagnosed with COVID-19 prior to the first dose of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Sore arm, fatigue, headache, sore eyea on 07Jan2021 03:00 AM with outcome of recovering. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.  Information on the lot/batch number has been requested.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Fatigue, Headache, Pain in extremity
Clinical narrative: Sore arm; fatigue; headache; sore eyea; This is a spontaneous report from a contactable other HCP. A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at 06Jan2021 06:45AM at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. The facility type vaccine was hospital. The patient medical history was not reported. Concomitant medication included hydrochlorothiazide, losartan potassium (HYZAAR), ibuprofen, omeprazole. The patient previously took amoxicillin and experienced drug hypersensitivity. Patient received the first dose of BNT162B2 at 16Dec2020 12:45 PM left arm for covid-19 immunization, then on 22Dec2020, patient tested Nasal Swab, the result was positive. Patient was not diagnosed with COVID-19 prior to the first dose of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Sore arm, fatigue, headache, sore eyea on 07Jan2021 03:00 AM with outcome of recovering. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.  Information on the lot/batch number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pain, Pruritus, Swelling, Tenderness
Clinical narrative: arm swollen, red, itchy, sore which started on 1/6,
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: arm swollen, red, itchy, sore which started on 1/6,
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: injection site reaction, redness, heat, swelling, pains welling to size of half dollar; injection site reaction, redness, heat, swelling, painswelling to size of half dollar; injection site reaction, redness, heat, swelling, painswelling to size of half dollar; injection site reaction, redness, heat, swelling, painswelling to size of half dollar; This is a spontaneous report from a contactable Nurse reported for herself. A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular at Left arm on 28Dec2020 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Workplace clinic. Medical history included binge eating disorder, anxiety. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), escitalopram oxalate (LEXAPRO), buspirone hydrochloride (BUSPAR), cetirizine hydrochloride (ZYRTEC) and birth control medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced injection site reaction, redness, heat, swelling, pain swelling to size of half dollar on 28Dec2020. No treatment was received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: injection site reaction, redness, heat, swelling, pains welling to size of half dollar; injection site reaction, redness, heat, swelling, painswelling to size of half dollar; injection site reaction, redness, heat, swelling, painswelling to size of half dollar; injection site reaction, redness, heat, swelling, painswelling to size of half dollar; This is a spontaneous report from a contactable Nurse reported for herself. A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular at Left arm on 28Dec2020 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Workplace clinic. Medical history included binge eating disorder, anxiety. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), escitalopram oxalate (LEXAPRO), buspirone hydrochloride (BUSPAR), cetirizine hydrochloride (ZYRTEC) and birth control medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced injection site reaction, redness, heat, swelling, pain swelling to size of half dollar on 28Dec2020. No treatment was received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Erythema, Lip swelling, Oropharyngeal discomfort
Clinical narrative: Anaphylaxis requiring administration of Epi
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Anaphylaxis requiring administration of Epi
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Livedo reticularis
Clinical narrative: Livedo reticularis (A reddish/purple pattern on the back of both legs); This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient (not pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number: EL0142; expiration date not provided) via an unspecified route of administration (anatomical location: Arm left) on 26Dec2020 09:00 at single dose for COVID-19 immunisation. Medical history included ongoing autoimmune disorder, ongoing 'immunocompromised' (taking Humira injections), and ongoing Prinzmetal angina; allergies to gadolinium, eggs, wasps/yellow jackets, and sulfa. Concomitant medications included adalimumab (HUMIRA), cetirizine hydrochloride (ZYRTEC), diltiazem hydrochloride (CARDIZEM), sulindac, and acetylsalicylic acid (ASPIRIN 81).  On 27Dec2020 at 11:00 am, the patient experienced livedo reticularis (A reddish/purple pattern on the back of both legs). No treatment was received for the event. It was reported that patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. It was also reported that it was unknown if patient was diagnosed with COVID prior to vaccination. It was further reported that since the vaccination, the patient has not been tested for COVID-19. Outcome of the event was recovering.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Flushing, Hypoaesthesia, Pruritus, Skin discolouration
Clinical narrative: right before the shot was given and the alcohol wipe touched my skin, my arm turned red. when instructed to sit and report any symptoms I noticed my arm started to itch. I let the nurse know, she had me checked out and my arm was a little red at the site. when I left, my arm stopped itching after 20 mins or so. Only symptom I can report was the site had a bump for a few days but has since gone away. No nausea, vomiting, diarrhea.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Stress
Clinical narrative: right before the shot was given and the alcohol wipe touched my skin, my arm turned red. when instructed to sit and report any symptoms I noticed my arm started to itch. I let the nurse know, she had me checked out and my arm was a little red at the site. when I left, my arm stopped itching after 20 mins or so. Only symptom I can report was the site had a bump for a few days but has since gone away. No nausea, vomiting, diarrhea.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site swelling, Pruritus
Clinical narrative: right before the shot was given and the alcohol wipe touched my skin, my arm turned red. when instructed to sit and report any symptoms I noticed my arm started to itch. I let the nurse know, she had me checked out and my arm was a little red at the site. when I left, my arm stopped itching after 20 mins or so. Only symptom I can report was the site had a bump for a few days but has since gone away. No nausea, vomiting, diarrhea.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: On or about 09:40-09:45 I felt a heaviness on the left side of my tongue and a general unwellness feeling, the heaviness persisted  and then as then somewhat of a continued presence that did not go away, later followed by a metallic taste in my mouth.  As I previously had a reaction to the first H1N1 vaccine years ago, I notified the person administering the vaccine before hand and also the nurse after the vaccine who was making her rounds.  I called her over to left her know I felt a little off/different, and described what I was feeling.  She escorted me to a private area where I was further assessed and given Benadryl 25mg po x 2.  The feeling never left my tongue and reportedly there was notation of questionable welts on the left side of my tongue. .I was able to speak clearly and swallow.  I was monitored and then discharged in the company of two of my colleagues (one an ICU nurse who works with me, and the other an ICU MD/anesthesiologist) who happened to be getting their vaccinations at the same time.  The tongue feeling did not leave me until late the next day and my lips felt a little off that night of the vaccine and the next day.  I continued to take the Tylenol and allegra as well as Benadryl.  By Friday night(1/8) I was feeling better, enough to work the weekend. Tylenol helped greatly for pain at injection site.  Today (1/12) I'm feeling not my best and  tired like yesterday but I had a busy weekend at work (RN in the COVID ICU), some malaise and achy (maybe my fibromyalgia or the weather), minor headache and fatigued, had a minor sore throat this am that has resolved, and Tylenol has resolved the headache.  Not sure if this needed to be included but I thought I'd mention it.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Fatigue, Feeling abnormal, Headache, Injection site pain
Clinical narrative: On or about 09:40-09:45 I felt a heaviness on the left side of my tongue and a general unwellness feeling, the heaviness persisted  and then as then somewhat of a continued presence that did not go away, later followed by a metallic taste in my mouth.  As I previously had a reaction to the first H1N1 vaccine years ago, I notified the person administering the vaccine before hand and also the nurse after the vaccine who was making her rounds.  I called her over to left her know I felt a little off/different, and described what I was feeling.  She escorted me to a private area where I was further assessed and given Benadryl 25mg po x 2.  The feeling never left my tongue and reportedly there was notation of questionable welts on the left side of my tongue. .I was able to speak clearly and swallow.  I was monitored and then discharged in the company of two of my colleagues (one an ICU nurse who works with me, and the other an ICU MD/anesthesiologist) who happened to be getting their vaccinations at the same time.  The tongue feeling did not leave me until late the next day and my lips felt a little off that night of the vaccine and the next day.  I continued to take the Tylenol and allegra as well as Benadryl.  By Friday night(1/8) I was feeling better, enough to work the weekend. Tylenol helped greatly for pain at injection site.  Today (1/12) I'm feeling not my best and  tired like yesterday but I had a busy weekend at work (RN in the COVID ICU), some malaise and achy (maybe my fibromyalgia or the weather), minor headache and fatigued, had a minor sore throat this am that has resolved, and Tylenol has resolved the headache.  Not sure if this needed to be included but I thought I'd mention it.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Oropharyngeal pain, Pain, Tongue discomfort, Urticaria
Clinical narrative: On or about 09:40-09:45 I felt a heaviness on the left side of my tongue and a general unwellness feeling, the heaviness persisted  and then as then somewhat of a continued presence that did not go away, later followed by a metallic taste in my mouth.  As I previously had a reaction to the first H1N1 vaccine years ago, I notified the person administering the vaccine before hand and also the nurse after the vaccine who was making her rounds.  I called her over to left her know I felt a little off/different, and described what I was feeling.  She escorted me to a private area where I was further assessed and given Benadryl 25mg po x 2.  The feeling never left my tongue and reportedly there was notation of questionable welts on the left side of my tongue. .I was able to speak clearly and swallow.  I was monitored and then discharged in the company of two of my colleagues (one an ICU nurse who works with me, and the other an ICU MD/anesthesiologist) who happened to be getting their vaccinations at the same time.  The tongue feeling did not leave me until late the next day and my lips felt a little off that night of the vaccine and the next day.  I continued to take the Tylenol and allegra as well as Benadryl.  By Friday night(1/8) I was feeling better, enough to work the weekend. Tylenol helped greatly for pain at injection site.  Today (1/12) I'm feeling not my best and  tired like yesterday but I had a busy weekend at work (RN in the COVID ICU), some malaise and achy (maybe my fibromyalgia or the weather), minor headache and fatigued, had a minor sore throat this am that has resolved, and Tylenol has resolved the headache.  Not sure if this needed to be included but I thought I'd mention it.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dizziness, Dysarthria, Electrocardiogram, Mouth swelling
Clinical narrative: ? Allergic Reaction     dizziness while getting covid shot    33-year-old female presents emergency department for reaction following COVID-19 vaccine.  Patient says she received her COVID-19 vaccine around 1630 today.  Following vaccine administration patient began to feel vertiginous and had sensation of tongue swelling.  Vertigo is worse with turning her head to the right.  She has had vertigo in the past.  She also had a slight metallic taste in her mouth and her nose began running.  Feels somewhat improved at this time.  Says she has not had any shortness of breath, wheezing, chest pain or tightness, rash/hives, itching, nausea, vomiting, abdominal pain, focal neurological symptoms, any other symptoms.  No history of prior anaphylactic reaction.  No history of reaction to vaccines in the past.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oral pruritus, Pain in extremity, Paraesthesia, Paraesthesia oral, Pharyngeal swelling
Clinical narrative: ? Allergic Reaction     dizziness while getting covid shot    33-year-old female presents emergency department for reaction following COVID-19 vaccine.  Patient says she received her COVID-19 vaccine around 1630 today.  Following vaccine administration patient began to feel vertiginous and had sensation of tongue swelling.  Vertigo is worse with turning her head to the right.  She has had vertigo in the past.  She also had a slight metallic taste in her mouth and her nose began running.  Feels somewhat improved at this time.  Says she has not had any shortness of breath, wheezing, chest pain or tightness, rash/hives, itching, nausea, vomiting, abdominal pain, focal neurological symptoms, any other symptoms.  No history of prior anaphylactic reaction.  No history of reaction to vaccines in the past.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rhinorrhoea, Swollen tongue, Taste disorder
Clinical narrative: ? Allergic Reaction     dizziness while getting covid shot    33-year-old female presents emergency department for reaction following COVID-19 vaccine.  Patient says she received her COVID-19 vaccine around 1630 today.  Following vaccine administration patient began to feel vertiginous and had sensation of tongue swelling.  Vertigo is worse with turning her head to the right.  She has had vertigo in the past.  She also had a slight metallic taste in her mouth and her nose began running.  Feels somewhat improved at this time.  Says she has not had any shortness of breath, wheezing, chest pain or tightness, rash/hives, itching, nausea, vomiting, abdominal pain, focal neurological symptoms, any other symptoms.  No history of prior anaphylactic reaction.  No history of reaction to vaccines in the past.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Electrocardiogram normal, Rhinorrhoea, Swollen tongue, Vertigo
Clinical narrative: ? Allergic Reaction     dizziness while getting covid shot    33-year-old female presents emergency department for reaction following COVID-19 vaccine.  Patient says she received her COVID-19 vaccine around 1630 today.  Following vaccine administration patient began to feel vertiginous and had sensation of tongue swelling.  Vertigo is worse with turning her head to the right.  She has had vertigo in the past.  She also had a slight metallic taste in her mouth and her nose began running.  Feels somewhat improved at this time.  Says she has not had any shortness of breath, wheezing, chest pain or tightness, rash/hives, itching, nausea, vomiting, abdominal pain, focal neurological symptoms, any other symptoms.  No history of prior anaphylactic reaction.  No history of reaction to vaccines in the past.